Bristol Myers Squibb has announced a partnership with Microsoft to develop AI tools for early lung cancer detection.

The collaboration will deploy FDA-approved radiology AI algorithms via Microsoft’s Precision Imaging Network, used by over 80% of US hospitals.

These AI tools analyze X-ray and CT images to identify lung nodules and support radiologists, potentially detecting cancer at earlier stages.

Lung cancer causes around 125,000 deaths annually in the US, with underserved populations facing higher mortality rates and lower screening rates.

The partnership aims to improve follow-up care for patients with incidental findings and expand access in rural and community clinics.

Bristol Myers Squibb emphasized streamlining workflows and enhancing patient outcomes, while Microsoft highlighted that AI could identify early signs of cancer before symptoms appear.

🔗 Source: Bristol Myers Squibb